Across TCGA pan-cancer cohorts, ZNF772 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated ZNF772 data layer compared with 15 for mass-spec protein.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher ZNF772 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated ZNF772 expression acts as an unfavorable survival marker.

SKCM, HNSC, and LUAD are the cancer types where ZNF772 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	OS	Median	IV	0.179	0.755	<.001	10	view →
HNSC	DFS	Median	All	0.185	0.626	.036	6	view →
LUAD	OS	Median	II,III,IV	0.090	0.677	<.001	6	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: ZNF772 tumor-vs-normal RNA expression · all ZNF772 data types